Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30.8M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
3.87M
-
Shares change
-
-356K
-
Total reported value, excl. options
-
$73.8M
-
Value change
-
-$5.83M
-
Put/Call ratio
-
1.8
-
Number of buys
-
25
-
Number of sells
-
-31
-
Price
-
$19.09
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q3 2020
74 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q3 2020.
XBiotech Inc. - Common Shares, no par value (XBIT) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.87M shares
of 30.8M outstanding shares and own 12.57% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.28M shares), VANGUARD GROUP INC (738K shares), NORTHERN TRUST CORP (305K shares), STATE STREET CORP (272K shares), GEODE CAPITAL MANAGEMENT, LLC (243K shares), Russell Investments Group, Ltd. (119K shares), Nuveen Asset Management, LLC (75.1K shares), WELLS FARGO & COMPANY/MN (72.3K shares), AQR CAPITAL MANAGEMENT LLC (63.7K shares), and CREDIT SUISSE AG/ (52.3K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.